Proximity extension assay
The proximity extension assay (PEA) is a method for detecting and quantifying the amount of many specific
Development
PEA is derived from the proximity ligation assay (PLA) which uses a DNA ligase enzyme to unite the sequences of the proximity probes instead of a DNA polymerase.[9][10] PLA is also suitable for multiplexing,[11] but suffers from enzymatic sample variable inhibition of ligase enzymes from components of serum and plasma samples. DNA polymerase enzymes do not suffer the same inhibition and is also readily multiplexable[12] and has been multiplexed up to 384 proteins.[13] PEA performance is temperature sensitive as it is a DNA hybridization-based reaction. So the use of hyper-thermostable polymerases with no activity at room temperature supports bench top reaction assembly.[12]
References
- PMID 21646338.
- PMID 28438806.
- ^ https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biomarker
- ^ https://www.fda.gov/media/116929/download
- S2CID 1902394.
- ^ https://www.biocompare.com/Editorial-Articles/187321-Multiplexed-Immunoassays/
- ^ "Olink announces milestone achievement of 1,000 peer-reviewed articles citing use of PEA technology" (Press release). 3 November 2022.
- ^ "1,000 peer-reviewed publication". 3 November 2022.
- S2CID 1269017.
- PMID 15155907.
- PMID 21242282.)
{{cite journal}}
: CS1 maint: unflagged free DOI (link - ^ PMID 24755770.
- PMID 34715355.